Sector Focus


Caliber has successfully planned with both venture backed private development stage companies and publicly traded biopharmaceutical companies. We understand the unique challenges of emerging companies as well as global biotech organizations and we have developed a keen sense of what it takes to discover and develop biologically derived treatments to enhance the quality of care in markets with substantially under met medical needs.


PMV Pharma

PMV Pharma is pioneering the discovery and development of p53 targeted small molecule drugs for the treatment of cancer. p53's importance in human biology is profound: it is the most commonly mutated protein in human cancers, with more than half of all tumors containing mutant p53.

Search Projects